Skip to content

To find out the current status in the prescribing pattern of antidepressant drugs in patients wit first depressive episode in PGIMS Rohtak OPD.

To evaluate the prescribing pattern of antidepressant drugs in patients with first depressive episode in a tertiary care hospital. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055333
Enrollment
58
Registered
2023-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G- Mental Health

Interventions

Control Intervention1: NIL: NIL

Sponsors

Pt BD Sharma PGIMS Rohtak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 All patients who are >= 18 years of age and are diagnosed with first depressive episode. 2 Male or female patients fulfilling ICD-10 criteria of first depressive episode. 3 Patients willing to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1 Patients with psychotic features. 2 History of any chronic physical or any other psychiatric illness. 3 Pregnant and lactating mothers 4 Patients with psychoactive substance use disorder

Design outcomes

Primary

MeasureTime frame
1 Average number of drugs per encounter 2 Percentage of drugs prescribed by generic name 3 Percentage of encounters with an antidepressant drug prescribed 4 Percentage of encounters with an injection prescribed 5 Percentage of drugs prescribed from the drug formularys essential drug list (EDL)Timepoint: Drug prescriptions will be analyzed by WHO/INRUD drug prescription indicators at baseline.

Secondary

MeasureTime frame
1. Naranjoâ??s adverse drug reactions (ADRs) probability scale for assessment of causality. 2. The WHO-UMC Causality assessment scale 3. Hartwig & Siegelâ??s Scale for assessment of the severity of adverse drug reactions (ADRs). 4. Schumock and Thornton criteria for adverse drug reaction (ADRs) preventability assessment.Timepoint: Adverse Drugs Reactions (ADRs) will be analyzed using various scales for casualty, severity, & preventability at 6 weeks of study.

Countries

India

Contacts

Public ContactDr Pawan Dhaka

Pt B. D. Sharma PGIMS Rohtak

jai123dhaka@gmail.com8745025208

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026